Huge Study Throws Cold Water on Antimalarials for COVID-19

Chloroquine or hydroxychloroquine (HCQ), with or without an antibiotic, in hospitalized COVID-19 patients were associated with increased risk of death in the hospital and higher rates of arrhythmias, analysis of outcomes in nearly 100,000 patients indicated.

The 15,000 patients who received HCQ or chloroquine were about twice as likely to die compared to controls who did not receive these agents after adjusting for covariates (18.o% for hydroxychloroquine and 16% for chloroquine versus 9.3% for controls), reported Mandeep Mehra, MD, of Brigham and Women’s Hospital in Boston, and colleagues.


share to facebook
share to twittershare to linkedinemail article

Huge Study Throws Cold Water on Antimalarials for COVID-19

Chloroquine or hydroxychloroquine (HCQ), with or without an antibiotic, in hospitalized COVID-19 patients were associated with increased risk of death in the hospital and higher rates of arrhythmias, analysis of outcomes in nearly 100,000 patients indicated.

The 15,000 patients who received HCQ or chloroquine were about twice as likely to die compared to controls who did not receive these agents after adjusting for covariates (18.o% for hydroxychloroquine and 16% for chloroquine versus 9.3% for controls), reported Mandeep Mehra, MD, of Brigham and Women’s Hospital in Boston, and colleagues.

The drug was also associated with a higher risk of ventricular arrhythmia during hospitalization (6.1% for hydroxychloroquine, 4.3% for chloroquine versus 0.3% for controls), the authors wrote in The Lancet.

Moreover, risks for both in-hospital mortality and ventricular arrhythmia were even higher compared to controls when either drug was combined with a macrolide antibiotic, they noted.

Mehra said in a statement these drugs should not be used as treatments for COVID-19 outside of clinical trials.

“This is the first large scale study to find statistically robust evidence that treatment with chloroquine or hydroxychloroquine does not benefit patients with COVID-19,” he said. “Instead, our findings suggest it may be associated with an increased risk of serious heart problems and increased risk of death. Randomised clinical trials are essential to confirm any harms or benefits associated with these agents.”

https://www.medpagetoday.com/infectiousdisease/covid19/86642?xid=nl_popmed_2020-05-22&eun=g381161d0r&utm_source=Sailthru&utm_medium=email&utm_campaign=CoronaBreak_052220&utm_term=NL_Daily_Breaking_News_Active

How you can tell this is an actual medical science study (for those going on and on about physicians saying it ‘cured virtually 100% of patients!’ with a study of 12 patients): Control group exists. Start and end date exists. Measurable factors listed. Factors for adjustment listed. Risk groups noted. Conclusion noted. Disclosures (interested parties) noted. Primary sources noted. No. Certainties. Noted.

%d bloggers like this: